Evaluated set of European data resources is of fundamental importance to the wider life-science community and the long-term preservation of biological data. ELIXIR aims to ensure that these resources are available long-term and that their life-cycles are managed so that they support the scientific needs of life-sciences and biological research.
ELIXIR Core Data Resource list
For an introduction to the Core Data Resources list, please view this summary.
ELIXIR has compiled a list of resources that it recommends for the deposition of experimental data. The scientific community has a shared responsibility to ensure long-term data preservation and accessibility. The purpose of this Deposition Databases list is to provide guidance to those who formulate policy and working practices about the appropriate repositories for publishing open data in the life sciences.
ELIXIR Deposition Database list
An ELIXIR Deposition Database is defined as being part of the ELIXIR Node portfolio of services that accepts deposition of experimental data from an international community of researchers beyond the funding envelope of the database itself.
Finland has a long tradition of collecting and analysing biobank samples and the associated clinical data. The National Institute for Health and Welfare (THL), the Institute for Molecular Medicine Finland (FIMM) and CSC – IT Center for Science will collaborate within the framework of three biomedical infrastructure projects in Europe: Biobanking and Biomolecular Resources Research Infrastructure (BBMRI), European Advanced Translational Research Infrastructure in Medicine (EATRIS) and European Life Science Infrastructure for Biological Information (ELIXIR).
BBMRI is responsible for biobanks utilised in both clinical research and research conducted on the health effects of lifestyle and the environment. EATRIS, in turn, applies the results of basic research to medical science.
Finnish Biobank Cooperative – FINBB was established in 2017 as part of the implementation of Finnish National Health Sector Growth Strategy to build an internationally high-standard biobank network in Finland. FINBB’s mission is to enhance the competitiveness of Finnish health and biomedical research by providing researchers a centralized access the collections and services of the Finnish biobanks and their background organizations. FINBB has been an official FinnGen partner as of August 2020.
FINBB has eight member biobanks:
In addition to the FINBB member biobanks, Blood Service Biobank and FHRB Biobank belong the Finnish biobank network. Terveystalo Biobank is a collaborator of the network.
| Data resource |
Institute | Description |
|---|---|---|
| SISu | FIMM | Sequencing Initiative Suomi (SISu) -The Sequencing Initiative Suomi (SISu) search engine offers a way to search for data on sequence variants in Finns. |
| FinHealth Study | THL | The purpose of the FinHealth Study is to collect up-to-date information on the health and well-being of adults residing in Finland, and on the factors influencing their health and well-being. |
| Findata | Finnish Social and Health Data Permit Authority | Findata grants permits for the secondary use of social and health care data and improve data protection for individuals. After granting the permit Findata compiles, combines and preprocesses it and offers tools for analysing. |
| Canine genetic studies | University of Helsinki and Folkhälsan Research Center | The aim of the canine genetic studies is to identify genetic abnormalities leading to different hereditary diseases, as well as other breed-specific traits, to develop genetic tests for purposes of breeding, and to use the gained knowledge in the study of human diseases. |
| Feline genetic studies | University of Helsinki and Folkhälsan Research Center | The feline DNA bank is beneficial for the research of genetic diseases and features. The large set of samples with updated health combined with other feature data of the cats (for example behaviour) makes countless and different gene studies possible. |
In case you have data resources to offer, please don´t hesitate to contact us servicedesk@csc.fi Subject “ELIXIR”
ELIXIR is partly funded by the European Commission